Rocket


News + Filings
Transactions
Holdings


All
13F
13D/G
Other

BAKER BROS. ADVISORS LP Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
10/05/2023 SC 13D/A BAKER BROS. ADVISORS LP reports a 10% stake in Madrigal Pharmaceuticals, Inc.
08/17/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
08/08/2023 SC 13D/A BAKER BROS. ADVISORS LP reports a 8.4% stake in Madrigal Pharmaceuticals, Inc.
07/19/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
06/28/2023 SC 13D/A BAKER BROS. ADVISORS LP reports a 10% stake in IGM Biosciences, Inc.
05/24/2023 SC 13D/A BAKER BROS. ADVISORS LP reports a 26.5% stake in ACADIA Pharmaceuticals Inc.
05/24/2023 SC 13D/A BAKER BROS. ADVISORS LP reports a 19.5% stake in Prelude Therapeutics Incorporated
05/05/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
05/03/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
03/15/2023 SC 13D/A BAKER BROS. ADVISORS LP reports a 16.4% stake in Incyte Corporation
03/13/2023 SC 13D/A BAKER BROS. ADVISORS LP reports a 25.3% stake in Seagen Inc.
03/10/2023 SC 13D/A BAKER BROS. ADVISORS LP reports a 66.2% stake in Talis Biomedical Corporation
01/17/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/20/2022 SC 13D/A BAKER BROS. ADVISORS LP reports a 9.9% stake in Immunocore Holdings plc
06/13/2022 SC 13D/A BAKER BROS. ADVISORS LP reports a 66.4% stake in Talis Biomedical Corporation
06/13/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
06/06/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
05/18/2022 SC 13D/A BAKER BROS. ADVISORS LP reports a 31.6% stake in Kodiak Sciences Inc.
05/12/2022 SC 13D/A BAKER BROS. ADVISORS LP reports a 14.7% stake in TScan Therapeutics, Inc.
04/05/2022 SC 13D/A BAKER BROS. ADVISORS LP reports a 11.6% stake in IGM Biosciences, Inc.
03/10/2022 SC 13D/A BAKER BROS. ADVISORS LP reports a 16.5% stake in Incyte Corporation
03/10/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
02/14/2022 SC 13D/A BAKER BROS. ADVISORS LP reports a 15.9% stake in Incyte Corporation
02/10/2022 SC 13D/A BAKER BROS. ADVISORS LP reports a 9.9% stake in Aeglea BioTherapeutics, Inc.
01/31/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
10/01/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/26/2021 SC 13D/A BAKER BROS. ADVISORS LP reports a 27.8% stake in Kodiak Sciences Inc.
05/18/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
05/18/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
04/02/2021 SC 13D/A BAKER BROS. ADVISORS LP reports a 67.5% stake in Talis Biomedical Corporation
03/19/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
03/05/2021 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
01/29/2021 SC 13D/A BAKER BROS. ADVISORS LP reports a 12.4% stake in IGM Biosciences, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy